Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease Uveitis

NCT02258867 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Behcet's Disease Uveitis

Interventions

DRUG: Placebo
DRUG: Gevokizumab

Sponsor

XOMA (US) LLC